Called Breast Cancer Ally, the application was developed after gathering feedback from both specialists who cared for patients and patients themselves.
The app will help clinicians and patients manage side effects of hypertension and diarrhoea, which can be associated with therapy with cediranib and olaparib.
The device and its companion app turn pretty much any smartphone into a portable colposcope, making the screening process available all around the world.
Apple announced that researchers from Duke University, Johns Hopkins and Oregon Health & Science University are launching new medical studies using ResearchKit.
The smart mole scanner, which is designed to be attached to a smartphone's camera, is now live on crowdfunding website Indiegogo.
Said therapy will be evaluated in a clinical trial in France, and will involve an app and telemedicine services to monitor patients between doctor visits.
The company will use the funds to widen applications for its technology beyond moles and melanomas, and expand into new geographical markets.
Of the 206 respondents to the survey, 93% of whom were women, 63% said they strongly agreed with the safe and welcoming statement, while 24% somewhat agreed.
After the trial is completed, the company will produce a wearable device (iTBra), which will utilize a comfortable data collection device placed under a bra.
The setup involves a mini-microscope that attaches to a smartphone, an app and a HIPAA-compliant cloud-based analytical platform called DermEngine.